Study Reveals Regulatory Mechanisms of AMP Deaminase-2 in Fructose and Nucleotide Metabolism
Researchers successfully expressed and purified human AMP deaminase-2 (hAMPD2-2) and characterized how ATP, GTP, and phosphate regulate its activity in fructose metabolism. The enzyme plays a key role in a metabolic pathway that produces uric acid, which is linked to gout, metabolic acidosis, and mitochondrial dysfunction. Understanding these regulatory mechanisms could enable development of targeted therapies to reduce harmful uric acid accumulation.
A new study published on bioRxiv describes the first successful expression and purification of human liver AMP deaminase-2 (hAMPD2-2) from bacterial cells, along with detailed characterization of its regulatory properties. Using steady-state kinetics, researchers found that ATP allosterically activates the enzyme at physiological concentrations (2-5 mM), with the activation site located in the catalytic domain. The study also revealed that GTP competitively inhibits the ATP-activated enzyme, while phosphate (Pi) plays a more complex regulatory role by enhancing GTP-mediated inhibition through competition at the ATP binding site. These findings suggest that under normal physiological conditions, the combination of GTP and Pi keeps uric acid production suppressed, but when these inhibitors are depleted, the pathway becomes active. The research provides a molecular foundation for designing targeted therapeutics to prevent excessive uric acid accumulation, which is associated with gout and other metabolic disorders.
What's missing
The study does not discuss potential clinical applications, timeline for therapeutic development, or how these findings compare to or build upon previous structural or kinetic studies of AMPD in other organisms beyond the brief mention of yeast AMPD.
What different sources said
- bioRxivCenter
Deciphering AMP deaminase-2 structure, activators and regulators underpinning cellular function in human fructose and nucleotide metabolism
Related
Study Links Specific Brain Stimulation Frequency to Speech Speed in Parkinson's Disease
Researchers found that low-frequency deep brain stimulation in the subthalamic nucleus selectively reduces a specific frequency band (15-23 Hz) associated with slower speech in Parkinson's disease patients. The study suggests this neural activity pattern could serve as a biomarker for speech tempo modulation. This finding may help optimize deep brain stimulation treatments to improve speech problems in Parkinson's patients.
Researchers Identify Complete Bacterial Pathway for Converting Bilirubin to Urobilinogen in Human Gut
Scientists have identified the complete enzymatic pathway by which gut bacteria convert bilirubin (a heme breakdown product) into urobilinogen, involving two enzymes: BilR and BilV. The discovery reveals that bilirubin metabolism requires two sequential reactions that can occur in either order, with BilV being a flavin-dependent enzyme widely distributed across gut bacteria. This finding is significant because bilirubin and its derivatives are linked to inflammatory and metabolic disorders, and understanding this pathway could enable better studies of how gut bacteria influence human health.
FEABAS: New Software Tool Improves Electron Microscopy Image Alignment for Brain Mapping
Researchers have developed FEABAS, an open-source software package that aligns and stitches millions of electron microscope images into coherent 3D volumes for neural circuit mapping. The tool uses adaptive mesh modeling and finite element methods to handle common imaging artifacts like wrinkles, folds, and tears without requiring intensive deep learning or manual editing. This advancement could make volume electron microscopy more accessible and practical for broader neuroscience research applications.